Skin Cancer Clinical Trials

A listing of Skin Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Texas

UPDATED

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Australia

UPDATED

Greenslopes Queensland 4120

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

North Sydney New South Wales 2060

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Austria

UPDATED

Graz 8036

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Salzburg A-5020

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Belgium

UPDATED

Brussels 1090

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Brussels 1200

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Ghent 9000

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Bulgaria

UPDATED

Plovdiv 4004

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Sofia 1303

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Canada

UPDATED

Edmonton Alberta T6G 1Z2

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Kingston Ontario K7L 2V7

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Montreal Quebec H3T 1E2

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Sherbrooke Quebec J1H 5N4

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

France

UPDATED

Marseille Cedex 05 13885

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Paris Cedex 10 75475

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Villejuif Cedex 94805

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Germany

UPDATED

Erlangen 91054

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Essen 45147

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Hanover 30625

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Heidelberg 69120

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Stade 21682

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Israel

UPDATED

Jerusalem 91120

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Ramat Gan 5265601

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Italy

UPDATED

Bergamo BG 24127

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Napoli 80131

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Japan

UPDATED

Chuo-ku Tokyo 104-0045

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Osaka-city Osaka 541-8567

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Netherlands

UPDATED

Groningen 9713 GZ

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Poland

UPDATED

Gdansk 80 952

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Lodz 95-513

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Poznan 60-355

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Warszawa 02-781

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Spain

UPDATED

Barcelona Catalunya 08035

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Barcelona Catalunya 08036

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Madrid 28034

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Madrid 28007

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Madrid 28050

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

View More ▼

UPDATED

Madrid 28041

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Pamplona Navarra 31008

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

San Sebastián Pais Vasco 20014

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Sevilla Andalucia 41009

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Valencia Comunidad Valenciana 46014

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Sweden

UPDATED

Lund 221 85

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Stockholm SE-171 76

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

Switzerland

UPDATED

Zuerich 8091

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

United Kingdom

UPDATED

London NW3 2QG

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Manchester M20 9BX

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Northwood Middlesex HA6 2RN

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma

UPDATED

Preston PR2 9HT

Patients are needed to participate in a clinical research study evaluating PDR001, Placebo, Dabrafenib and Trametinib for the treatment of Melanoma